The global market for Lipidic Cubic Phase Crystallization Service was valued at US$ 320 million in the year 2024 and is projected to reach a revised size of US$ 492 million by 2031, growing at a CAGR of 6.4% during the forecast period.
Lipidic Cubic Phase (LCP) has become a popular technique for membrane protein crystallization. It has been particularly useful in the field of G-protein Coupled Receptor Protein research, leading to numerous structure solutions. It is the result of mixing aqueous and surfactant components to form a lattice of quasi-lipid phase and aqueous channels that can support membrane protein crystal growth.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
This report aims to provide a comprehensive presentation of the global market for Lipidic Cubic Phase Crystallization Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lipidic Cubic Phase Crystallization Service.
The Lipidic Cubic Phase Crystallization Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lipidic Cubic Phase Crystallization Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lipidic Cubic Phase Crystallization Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Âé¶¹Ô´´ Segmentation
By Company
Cube Biotech
Creative Biostructure
Formulatrix
Anatrace
Jena Bioscience GmbH
Segment by Type
Monoolein
Monopalmitolein
Others
Segment by Application
Pharmaceutical Companies
Academic Research Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lipidic Cubic Phase Crystallization Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoolein
1.2.3 Monopalmitolein
1.2.4 Others
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Academic Research Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Perspective (2020-2031)
2.2 Global Lipidic Cubic Phase Crystallization Service Growth Trends by Region
2.2.1 Global Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Size by Region: 2020 VS 2024 VS 2031
2.2.2 Lipidic Cubic Phase Crystallization Service Historic Âé¶¹Ô´´ Size by Region (2020-2025)
2.2.3 Lipidic Cubic Phase Crystallization Service Forecasted Âé¶¹Ô´´ Size by Region (2026-2031)
2.3 Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Dynamics
2.3.1 Lipidic Cubic Phase Crystallization Service Industry Trends
2.3.2 Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Drivers
2.3.3 Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Challenges
2.3.4 Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lipidic Cubic Phase Crystallization Service Players by Revenue
3.1.1 Global Top Lipidic Cubic Phase Crystallization Service Players by Revenue (2020-2025)
3.1.2 Global Lipidic Cubic Phase Crystallization Service Revenue Âé¶¹Ô´´ Share by Players (2020-2025)
3.2 Global Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Lipidic Cubic Phase Crystallization Service Revenue
3.4 Global Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lipidic Cubic Phase Crystallization Service Revenue in 2024
3.5 Global Key Players of Lipidic Cubic Phase Crystallization Service Head office and Area Served
3.6 Global Key Players of Lipidic Cubic Phase Crystallization Service, Product and Application
3.7 Global Key Players of Lipidic Cubic Phase Crystallization Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lipidic Cubic Phase Crystallization Service Breakdown Data by Type
4.1 Global Lipidic Cubic Phase Crystallization Service Historic Âé¶¹Ô´´ Size by Type (2020-2025)
4.2 Global Lipidic Cubic Phase Crystallization Service Forecasted Âé¶¹Ô´´ Size by Type (2026-2031)
5 Lipidic Cubic Phase Crystallization Service Breakdown Data by Application
5.1 Global Lipidic Cubic Phase Crystallization Service Historic Âé¶¹Ô´´ Size by Application (2020-2025)
5.2 Global Lipidic Cubic Phase Crystallization Service Forecasted Âé¶¹Ô´´ Size by Application (2026-2031)
6 North America
6.1 North America Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Size (2020-2031)
6.2 North America Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Size by Country (2020-2025)
6.4 North America Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Size (2020-2031)
7.2 Europe Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Size by Country (2020-2025)
7.4 Europe Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Size (2020-2031)
8.2 Asia-Pacific Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Size by Region (2020-2025)
8.4 Asia-Pacific Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Size (2020-2031)
9.2 Latin America Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Size by Country (2020-2025)
9.4 Latin America Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Size (2020-2031)
10.2 Middle East & Africa Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Size by Country (2020-2025)
10.4 Middle East & Africa Lipidic Cubic Phase Crystallization Service Âé¶¹Ô´´ Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cube Biotech
11.1.1 Cube Biotech Company Details
11.1.2 Cube Biotech Business Overview
11.1.3 Cube Biotech Lipidic Cubic Phase Crystallization Service Introduction
11.1.4 Cube Biotech Revenue in Lipidic Cubic Phase Crystallization Service Business (2020-2025)
11.1.5 Cube Biotech Recent Development
11.2 Creative Biostructure
11.2.1 Creative Biostructure Company Details
11.2.2 Creative Biostructure Business Overview
11.2.3 Creative Biostructure Lipidic Cubic Phase Crystallization Service Introduction
11.2.4 Creative Biostructure Revenue in Lipidic Cubic Phase Crystallization Service Business (2020-2025)
11.2.5 Creative Biostructure Recent Development
11.3 Formulatrix
11.3.1 Formulatrix Company Details
11.3.2 Formulatrix Business Overview
11.3.3 Formulatrix Lipidic Cubic Phase Crystallization Service Introduction
11.3.4 Formulatrix Revenue in Lipidic Cubic Phase Crystallization Service Business (2020-2025)
11.3.5 Formulatrix Recent Development
11.4 Anatrace
11.4.1 Anatrace Company Details
11.4.2 Anatrace Business Overview
11.4.3 Anatrace Lipidic Cubic Phase Crystallization Service Introduction
11.4.4 Anatrace Revenue in Lipidic Cubic Phase Crystallization Service Business (2020-2025)
11.4.5 Anatrace Recent Development
11.5 Jena Bioscience GmbH
11.5.1 Jena Bioscience GmbH Company Details
11.5.2 Jena Bioscience GmbH Business Overview
11.5.3 Jena Bioscience GmbH Lipidic Cubic Phase Crystallization Service Introduction
11.5.4 Jena Bioscience GmbH Revenue in Lipidic Cubic Phase Crystallization Service Business (2020-2025)
11.5.5 Jena Bioscience GmbH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Âé¶¹Ô´´ Size Estimation
13.1.1.3 Âé¶¹Ô´´ Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Cube Biotech
Creative Biostructure
Formulatrix
Anatrace
Jena Bioscience GmbH
Ìý
Ìý
*If Applicable.